J&J CEO testifies on the Hill

Johnson & Johnson's CEO Bill Weldon testified before a congressional committee today, acknowledging that McNeil Consumer Healthcare should have handled the recall of medicines like Motrin "differently."

Johnson & Johnson's CEO Bill Weldon testified before a congressional committee today, acknowledging that McNeil Consumer Healthcare should have handled the recall of medicines like Motrin "differently."

The company recalled 40 medicines this year after consumers reported instances of nausea and stomach pain and Food and Drug Administration inspectors found problems at a manufacturing plant.

What furthermore raised questions about its actions was the decision for the company to buy out defective Motrin medicines although FDA has also been criticized for its knowledge of that plan.

In recent months, Weldon announced that the company was reorganizing its manufacturing unit and named company veteran Ajit Shetty to oversee manufacturing and quality control.

And, The New York Times noted earlier that Weldon had increasingly spoken out that the recalls are not a reflection of problems across the company. In addition, Johnson & Johnson said this week that it plans to reintroduce Liquid Children's Tylenol. 

The Wall Street Journal's Heath Blog is updating Thursday's testimonies throughout the day.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.